- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04197466
Comparison of Different Treatments for Overactive Bladder Syndrome
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Ankara yıldırım Beyazıt Üniversitesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women
- Being Volunteered to participate
- Diagnosed as overactive bladder
Exclusion Criteria:
- Pregnant women
- Patients with a comorbid neurological disorder
- A mental problem that may prevent cooperation and evaluation
- Acute infection
- Sensory loss
- Malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pelvic Floor Exercise Group
Pelvic floor muscle exercises will be recommended as a home program for 6 weeks every day of the week.
|
The exercise program will be tailored according to the pelvic floor muscle strength, including fast and slow contractions.
The number and duration of exercises will be increased according to progress..
|
Experimental: Kinesiotape Group
In addition to pelvic floor exercise,kinesio tape application will be performed by ligament technique to the sacral region.
|
The exercise program will be tailored according to the pelvic floor muscle strength, including fast and slow contractions.
The number and duration of exercises will be increased according to progress..
Kinesio tape application will be performed by ligament technique to the sacral region.
|
Experimental: Electrical Stimulation Group
In addition to pelvic floor exercise,electrical stimulation will be performed in the lying, sitting, stand up positions for 30 minutes
|
The exercise program will be tailored according to the pelvic floor muscle strength, including fast and slow contractions.
The number and duration of exercises will be increased according to progress..
External electrical stimulation will be performed in the lying, sitting, stand up positions for 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bladder Diary
Time Frame: Before the treatment, at end of 6 weeks
|
Women will be asked to complete a 24-hour frequency-volume chart (urine diary) to assess bladder symptoms.
Each woman will fill the chart for a total of 3 days filled in 3 consecutive days.
In these diaries, women will be asked to record the number of their urination during the day, how much urine they produce each time they urinate, their incontinence, the type and amount of drinks.
Women will be warned not to change their daily voiding habits and the amount of fluids they consume during filling these charts.
The data obtained from these three days will be averaged to determine daily voiding frequency, night voiding frequency, average voiding volume, and daily urinary incontinence.
|
Before the treatment, at end of 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
King Health Questionnaire
Time Frame: Before the treatment and end of 6 weeks
|
The Turkish version of the King Health Questionnaire, which was developed to assess the quality of life of women, consisting of 21 items, was shown to be valid and reliable The survey consists of 3 sections and 9 sub-headings.
These subheadings are questions that determine general health perception, incontinence impact, role, physical and social limitations, personal relationships, emotions, sleep / energy and severity measures.
In addition, the third section includes 9 questions that question the effect of urinary symptoms.
In each subheading, a complex scoring algorithm is used for missing values.
Scoring varies between "0" and "100.. Decrease in score indicates an increase in quality of life
|
Before the treatment and end of 6 weeks
|
Pelvic Floor Muscle Strength
Time Frame: Before the treatment and end of 6 weeks
|
Modified Ashword Scale and perineometer device will be used for the measurement of the pelvic floor muscle strength. Modified Ashword Scale is a 6-point scale: 0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong. This measurement scale is incorporated with vaginal palpation in the clinical assessment,. The PFX perineometer (Cardio Design Pty Ltd, Australia) will be used to provide an objective measurement. In the lithotomy position the probe of the perineometer will be inserted into the vagina of the patient. The patient will be asked to relax and squeeze the probe of the perineometer as if they are holding the urine or gaita. The minimum and maximum value of the perineometer are between 0-12 kg Pascal (kPa) and the difference between the first value and the last value in the perineometer will be determined as the pelvic floor muscle strength. The average of three repetitions will be noted |
Before the treatment and end of 6 weeks
|
Overactive bladder symptoms
Time Frame: Before the treatment, at end of 6 weeks
|
Symptoms will be assessed by the Turkish version of the Overactive Bladder-V8 (OAB-V8) questionnaire, which has been shown to be valid and reliable.
The AAM-V8 questionnaire had 8 questions scored as 0 to 5. The total score ranges from 0 to 40.
Increased scores indicate that the severity of overactive bladder complaints increases.
|
Before the treatment, at end of 6 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018/06/09
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overactive Bladder
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Merck Sharp & Dohme LLCTerminatedOveractive Bladder | Overactive Urinary Bladder
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Beijing Pins Medical Co., LtdUnknown
-
Maastricht University Medical CenterUnknownLower Urinary Tract Symptoms | Overactive Bladder SyndromeNetherlands
-
Pamukkale UniversityCompletedElectrical Stimulation | Idiopathic Overactive Bladder | Bladder TrainingTurkey
-
Astellas Pharma Singapore Pte. Ltd.CompletedOveractive Bladder (OAB)Korea, Republic of, Australia
Clinical Trials on Pelvic Floor Exercise Group
-
Fundación Pública Andaluza para la Investigación...CompletedUrinary Incontinence | Pelvic Floor Muscle Weakness | Electroacupuncture | WomenSpain
-
Seyda TOPRAK CELENAYUnknown
-
Cairo UniversityNot yet recruitingUrinary Stress Incontinence
-
Quirón Madrid University HospitalCompletedMusculoskeletal Pain | Pelvic Pain | Pelvic Floor Disorders | Perineal Tear | DyspareuniaSpain
-
Kwong Wah HospitalUnknown
-
Cairo UniversityCompleted
-
Taipei Medical University WanFang HospitalUnknown
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Serap TekbasCompletedPelvic Floor Muscle Weakness | SexualityTurkey
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)Completed